Radiology / Nuclear Medicine News from Medical News Today

If you’ve ever stared at an X-ray wondering how on earth a cloudy black-and-white image can tell your doctor
what’s wrong, welcome to the endlessly fascinating world of radiology and nuclear medicine. From simple chest
X-rays to sophisticated PET/CT scans that light up tiny pockets of cancer, this field is moving faster than a CT
scanner can spin. Medical News Today’s Radiology / Nuclear Medicine section has become a go-to hub for
translating this highly technical world into language that patients (and curious clinicians) can actually understand.

In this guide, we’ll walk through the latest radiology and nuclear medicine news that outlets like
Medical News Today, major medical societies, and U.S. regulators are spotlighting right now. We’ll dig into
cutting-edge artificial intelligence (AI), cancer-targeting nuclear therapies, booming imaging-center growth,
and what all of this means for safety and real people lying on scanners every day.

Radiology and Nuclear Medicine 101: More Than Just “Taking Pictures”

From X-rays to PET scans: how modern imaging works

Radiology is the umbrella term for medical imaging technologies that visualize what’s going on inside the body.
Classic tools include X-rays, CT (computed tomography), MRI (magnetic resonance imaging), ultrasound, and
mammography. Nuclear medicine adds a twist: instead of just shining energy at the body, it uses tiny amounts
of radioactive tracers that travel through the body and highlight organs, bones, or tumors based on how they
function, not just how they look.

Medical News Today’s radiology and nuclear medicine articles often start by demystifying basics like how X-rays
are performed, what radiation dose means, and when tests such as PET/CT, bone scans, or thyroid scans are used.
Their editorial policy leans heavily on peer-reviewed research and major medical associations, helping readers
separate solid science from internet rumor.

Why nuclear medicine matters

Nuclear medicine exams can detect disease earlier than many structural imaging tests because they track
metabolism, blood flow, or receptor activity at the cellular level. That’s crucial in cancer, heart disease, and
neurological conditions, where catching small changes early can dramatically affect outcomes. The newest wave of
nuclear medicinetheranosticsactually combines imaging and treatment in one package, allowing doctors to
see and treat cancer using the same molecular target. We’ll come back to that game-changer in a bit.

Big Trend #1: AI Is Rewriting (Not Replacing) the Radiology Playbook

A decade ago, a few high-profile commentators predicted that AI would put radiologists out of work. Fast-forward
to 2025, and the reality is very different: radiologists are still very much employed, and AI has settled into the
role of hyper-diligent assistant rather than ruthless replacement.

Hundreds of AI tools, mostly in imaging

Recent research published in major journals and summarized by outlets such as JAMA Network Open and Radiology
Business shows that close to 1,000 AI and machine-learning medical devices have now been cleared by the U.S.
Food and Drug Administration (FDA), and roughly three-quarters of them are used in radiology. Many of these
tools analyze CT, MRI, or X-ray images to:

• Flag possible strokes, brain bleeds, or large vessel occlusions on CT scans.
• Highlight suspicious nodules in lung cancer screening CTs.
• Support mammogram reading by marking potential cancers.
• Estimate organ volumes or cardiac function from MRI automatically.

The FDA even maintains a dedicated AI-enabled medical device list, which is updated regularly so clinicians and
innovators can see exactly which tools have been cleared for use in U.S. practice. This isn’t some sci-fi preview;
it’s already in everyday clinical workflows.

The catch: plenty of approvals, not always plenty of real-world testing

Here’s the twist most headlines miss: while hundreds of AI devices are authorized, less than one-third of
radiology AI tools have undergone robust clinical testing in real-world patient populations before approval.
Many rely on retrospective datasets from a limited number of hospitals. That means:

• Performance can drop when the model meets a different population than it was trained on.
• Subtle biases (for example, less accurate results in under-represented groups) may not surface until later.
• Radiologists still have to verify, correct, and contextualize AI suggestions.

Large outlets like The Washington Post have highlighted how AI in radiology is changing practice without
eliminating the human expert. The emerging consensus is simple and sensible: a human plus a machine is better
than either alone. Radiologists are still accountable for final reports, and many hospitals require AI outputs to
be clearly labeled decision support, not automatic truth.

What this means for patients

For patients, AI mostly shows up behind the scenes. Your CT scan may get “triaged” by an algorithm that bumps
critical-looking findings to the top of the radiologist’s worklist, shaving minutes off life-saving decisions.
Future tools are also pushing into report drafting and personalized follow-up recommendations. But you should still
expect a human radiologist to interpret your exam and your doctor to explain what it means for your overall care.

Big Trend #2: Theranostics and PSMA PET Are Transforming Cancer Care

If AI is the headline-grabbing brain of modern imaging, theranostics is its precision-guided missile. The term
combines “therapy” and “diagnostics” and describes approaches where a molecular target is used both to
find cancer and to treat it using radioactive particles.

PSMA PET for prostate cancer

One of the biggest breakthroughs comes from prostate-specific membrane antigen (PSMA) PET imaging. Research
summarized by cancer journals and academic centers in the U.S. shows that PSMA PET scans can detect tiny
prostate cancer deposits that older imaging often misses. This matters hugely when:

• Staging a new diagnosis (deciding whether surgery, radiation, or systemic therapy makes sense).
• Looking for recurrence after rising PSA levels.
• Planning focused radiation to just a few metastatic spots.

Conferences like “PSMA & Beyond,” co-hosted by major U.S. universities and the Prostate Cancer Foundation,
now center whole sessions on how PSMA PET is reshaping treatment algorithms. The consensus: it’s not just a
better picture; it’s a better way to decide who gets which therapy and when.

From seeing tumors to attacking them

The next step is radioligand therapy: using a PSMA-targeting molecule linked to a radioactive payload that
delivers lethal radiation straight into prostate cancer cells. New clinical trial data presented at oncology
and radiation-therapy meetings show that adding PSMA-targeted radioligand therapy to standard metastasis-directed
radiation can delay progression and postpone the need for long-term hormone therapygiving patients more time
with fewer systemic side effects.

Cancer centers like Memorial Sloan Kettering Cancer Center (MSK) detail how theranostics is expanding beyond
prostate cancer as well. Labs are exploring alpha-emitting radiopharmaceuticals, which deliver extremely potent
hits of radiation over very short distances, potentially increasing tumor kill while sparing nearby tissues.

Beyond prostate cancer: FAPI, neuroendocrine tumors, and more

PSMA may be the star, but it’s not alone. Nuclear medicine departments in the U.S. and worldwide are rapidly
adopting tracers like:

• DOTA-labeled agents for imaging and treating neuroendocrine tumors.
• FAPI tracers that target fibroblast activation protein, useful for cancers with low FDG uptake and certain fibrotic diseases.
• Exendin-based tracers to localize rare insulin-secreting tumors.

Academic nuclear medicine programs now train residents to think less like “photographers” and more like
molecular strategists, choosing the right tracer and, increasingly, the right therapeutic partner based on the
biology of each patient’s disease.

Big Trend #3: Imaging Centers, New Hardware, and the Business of Scanning

Radiology and nuclear medicine don’t happen in a vacuum; they happen in real imaging centers with real budgets
and very real waiting rooms. Industry reports on U.S. diagnostic imaging centers show a sector that’s growing
steadily, driven by:

• An aging population that needs more cancer, heart, and bone imaging.
• New applications like lung cancer screening CT and whole-body MRI research.
• Greater payer acceptance of imaging when it’s clearly tied to improved outcomes and guidelines.

Large radiology networks are investing in new centers across multiple states, while manufacturers roll out next-gen
scanners with faster acquisition times, quieter MRI bores, and lower radiation doses. Trade publications such as
Imaging Technology News cover product launches like advanced ultrasound systems showcased at RSNA (the
Radiological Society of North America’s flagship meeting), new PET/CT platforms, and cloud-native image
management systems designed for teleradiology and multi-site health systems.

AI built right into the machines

Another subtle shift: AI is no longer only a separate piece of software; it’s increasingly built straight into
scanners. Cardiac MRI platforms, for example, now ship with AI-based tools that automatically segment the heart
and generate quantitative tissue maps, helping cardiologists detect fibrosis or inflammation earlier than before.

For patients, this may translate into shorter exam times, more precise measurements, and, ideally, fewer repeat
scans due to motion or suboptimal image quality.

Safety, Radiation Dose, and Patient-Centered Imaging

Whenever radiation enters the conversation, so do safety worriesand that’s completely reasonable. Earlier media
coverage raised concerns that CT scans could significantly increase lifetime cancer risk, while other research
suggested those fears might be overstated when real-world doses and benefits are taken into account.

Today, radiology societies and international agencies emphasize three key principles:

• Justification: Any imaging study that uses radiation (X-ray, CT, nuclear medicine) should have a clear expected benefit that outweighs the risk.
• Optimization: Use the lowest dose that still produces diagnostic-quality images.
• Personalization: Tailor protocols based on age, body size, and clinical question; a child, for example, shouldn’t simply receive a scaled-up adult dose.

Organizations like the American College of Radiology (ACR) promote “Image Wisely” and “Image Gently” campaigns,
which encourage clinicians and technologists to think critically before ordering or performing a scan. Meanwhile,
patient-facing sites such as Medical News Today help explain why, in many situations, the immediate benefit of
detecting a stroke, pulmonary embolism, or aggressive cancer far exceeds the small theoretical radiation risk.

How Medical News Today Curates Radiology / Nuclear Medicine Updates

Medical News Today’s Radiology / Nuclear Medicine category acts like a curated digest of what’s happening across
imaging research, clinical guidelines, and patient questions. You’ll find:

• Explainers on imaging basics, like “What is nuclear medicine?” or “How safe are X-rays?”
• Condition-specific deep dives, such as how radiology helps diagnose rheumatoid arthritis or track chronic lung disease.
• Coverage of emerging topics, from theranostics to AI-guided image interpretation.
• Patient-friendly Q&A articles on how to prepare for scans, what contrast is, and what results might mean.

Their editorial process leans on guidelines from professional societies, peer-reviewed journals, and large
academic centers. This helps keep the content aligned with mainstream medical practice rather than trending
social-media myths.

Putting It All Together: What Patients and Clinicians Should Watch Next

Radiology and nuclear medicine are in a high-speed evolution cycle. Here are a few practical takeaways from the
latest news:

• AI is here to staynot as a replacement, but as a second set of eyes that can speed up workflows and catch patterns humans sometimes miss.
• Theranostics is expanding, starting with prostate and neuroendocrine cancers and slowly spreading to other tumor types as new tracers are developed.
• Imaging centers are getting smarter, integrating cloud platforms, teleradiology, and embedded AI to deliver faster, more consistent care.
• Safety remains central; dose-reduction techniques and careful justification are now part of everyday practice, not after-thoughts.
• Trustworthy patient information matters; curated sites like Medical News Today can help people ask better questions and understand why a scan is (or isn’t) being recommended.

In other words, if you’re picturing radiology as a quiet dark room where someone passively reads films, update
that mental image. Today’s imaging world is a busy intersection of physics, molecular biology, data science, and
compassionate patient care.

What This Looks Like in Real Life: Experiences from the Imaging Suite

News headlines and conference abstracts are great, but radiology and nuclear medicine really come alive in
day-to-day stories. While every patient is unique, certain patterns repeat across hospitals and imaging centers.
Here are a few composite scenarios that capture how these trends play out in practice.

A rheumatoid arthritis patient and the power of imaging follow-up

Imagine a middle-aged person with rheumatoid arthritis whose joints flare, calm down, and flare again. At first,
simple hand X-rays show only mild changes. Over the years, follow-up imagingX-rays and occasional MRIhelps the
rheumatologist see whether bone erosion is progressing. When the treatment plan changes (for example, switching
to a biologic medication), imaging gives objective evidence that joint damage has slowed. Without radiology,
the team would be relying only on pain scores and exam findings, which can be surprisingly misleading.

Articles in Medical News Today about rheumatoid arthritis and radiology help people understand why imaging is
repeated over time and why “nothing dramatic” showing up on a scan can still be very good news: it means the
disease is under better control than the symptoms alone might suggest.

A prostate cancer survivor discovering PSMA PET

Another scenario: a man treated for localized prostate cancer sees his prostate-specific antigen (PSA) start
creeping up years later. Traditional imagingCT, bone scan, MRIcan’t find where the recurrence is hiding. That’s
terrifying: something is there, but no one can see it.

Enter PSMA PET. With this tracer, tiny metastatic deposits in lymph nodes or bones may finally show up. Instead
of going straight to lifelong hormone therapy with broad systemic side effects, the care team can consider
targeted radiation to a small number of lesions or carefully planned additional surgery. Medical News Today’s
coverage of PSMA PET and theranostics helps patients and families understand why the doctor is suddenly ordering
a scan they’ve never heard ofand why it might open up new, more personalized options.

Radiologists learning to “speak AI”

On the other side of the monitor sit radiologists who trained in an era of conventional imaging and now find
themselves working with AI-enhanced workflows. Many describe the early experience as a mix of excitement and
skepticism: the algorithm flags a suspected stroke on a CT scan that looks almost normal on first pass. Double-checking
reveals a subtle abnormality they might have eventually found but not nearly as quickly.

Over time, these clinicians develop a feel for where AI shines (triaging large volumes of images, measuring
subtle changes in lesion size) and where it struggles (unusual anatomy, hardware artifacts, or patients who look
nothing like the training data). They also see firsthand why clinical testing and regulatory oversight matter:
if a tool over-calls too many findings, it wastes time; if it under-calls, it can be dangerous. Real-world use
turns AI from a shiny promise into a practical, constantly improving partner.

A nuclear medicine technologist balancing precision and reassurance

Nuclear medicine technologists sit at a unique crossroads. They prepare radioactive tracers, position patients,
and operate PET or SPECT camerasbut they also spend time in the room answering nervous questions like “Will I
be radioactive forever?” or “Can I hug my grandchildren after this?”

Their experience reflects how modern nuclear medicine blends high-tech science with human reassurance. For
example, they might explain that the tracer used for a PET scan has a very short half-life and that most of it
is gone from the body within hours. They show patients how to stay hydrated to flush the tracer faster and may
offer simple tipslike keeping some distance from small children for a limited timeas an extra precaution.

Patient-education pieces from Medical News Today and similar outlets give technologists and nurses an accessible
resource they can recommend, so people can re-read information later instead of trying to remember every detail
from a stressful day.

Health systems planning for the future

Finally, hospital leaders and imaging-center administrators are reading many of the same industry reports that
show up in radiology news feeds. They see projections about growing demand, new reimbursement rules, and the cost
of next-generation scanners. Their “experience” is less about individual scans and more about making sure
communities have access to appropriate imaging without exploding costs.

For them, news about AI-enabled devices, cloud-based image sharing, and teleradiology is directly tied to
decisions about which systems to purchase, which subspecialists to recruit, and how to standardize imaging
protocols across multiple sites. Well-reported articles on these topics help ensure that those decisions are
grounded in evidence, not just vendor marketing slide decks.

Put together, these experiencesfrom patients facing new tests to clinicians adopting new tools and health
systems planning long-termshow why radiology and nuclear medicine news is more than just technology hype. It’s
a window into how modern medicine is reorganizing itself around earlier detection, more precise targeting, and
smarter use of data.

SEO Recap: Metadata for Your Article

PSMA PET theranostics, with insights inspired by Medical News Today.

sapo: Radiology and nuclear medicine are changing fastfrom AI that flags strokes in minutes to
theranostic tracers that both find and treat cancer. In this in-depth guide, inspired by the Radiology / Nuclear
Medicine coverage from Medical News Today and major U.S. medical sources, you’ll learn how imaging tests really
work, why PSMA PET and targeted radioligand therapies are rewriting prostate cancer care, how AI is transforming
(but not replacing) radiologists, and what all of this means for patient safety, imaging centers, and everyday
experiences in the scanner. Whether you’re a patient, caregiver, or healthcare professional, this overview helps
you follow the latest imaging news with confidence.